Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 30;11:714756. doi: 10.3389/fonc.2021.714756

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Wang, Liu, Li, Li, Li and Zhu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Hepcidin correlates with a worse survival outcome in liver cancer patients. (A) Patient survival outcome was analyzed on the Kaplan-Meier Plotter platform. Hepcidin expression levels were ranged as 0-120133 and the cutoff value for hepcidin expression was set as 501 in the overall and disease-specific survival analysis and 82 for the relapse-free survival using the minimum p-value approach as described (26). Case numbers in each group were listed at the bottom of the figure. (B) The cutoff value for hepcidin expression was 48 in the relapse-free survival comparison. (C) Hepcidin expression range was 0-66150 and the cutoff value was 511 for all three comparisons.